Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension

Authors: Losartan Trial Investigators; Manolis A.J.; Grossman E.; Jelakovic B.; Jacovides A.; Bernhardi D.C.; Cabrera W.J.; Watanabe L.A.; Barragan J.; Matadamas N.; Mendiola A.; Woo K.S.; Zhu J.R.; Mejia A.D.; Bunt T.; Dumortier T.; Smith R.D.1

Source: Clinical Therapeutics, Volume 22, Number 10, October 2000 , pp. 1186-1203(18)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: angiotensin II antagonist; antihypertensive therapy; losartan; candesartan hydrochlorothiazide

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(00)83062-3

Affiliations: 1: nMerck & Co, Inc, , Whitehouse Station, New Jersey, U.S.A.

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A